KingMed & Cepheid China are joining forces to jointly promote accurate diagnosis of infectious diseases!

On August 12, 2022, Guangzhou Kingmed Diagnostics Group Co.,Ltd and Cepheid China signed a strategic cooperation agreement in Guangzhou to jointly promote the accurate diagnosis of clinical infectious diseases such as tuberculosis, hospital-acquired infection, drug-resistant bacterial infection, and carry out long-term in-depth cooperation. Guangzhou Kingmed Diagnostics Group Medical Laboratory Center has introduced the GeneXpert® Infinity System, a Cepheid assembly line, to jointly build the "GeneXpert® Automation Demonstration Laboratory".

Peng Yang, Vice President of Danaher Global and President of China Group, said: We hope that through this cooperation with Kingmed, can further respond to the national "14th Five-Year Plan" goal. The philosophy of Kingmed is consistent with that of Danaher. We hope to transform the international cutting-edge technology into products that serve the common people. Danaher has good technologies and ideas, and Kingmed has a very complete clinical testing service system. Based on this cooperation foundation, we can build a more long-term sustainable cooperation model in the future.

Liang Yaoming, Chairman and CEO of Kingmed said that: Cepheid is a leader in the field of infectious disease diagnosis in the world. Kingmed has always attached great importance to the innovation and development of infectious diseases and is committed to building a national leading infectious disease diagnostic test. room. The strong alliance with Cepheid will better promote the innovation and development of pathogen diagnosis technology, improve the domestic infectious disease diagnosis level, and help the construction of China's public health system.

Cepheid China General Manager Ms. Dong Wei said:

The Cepheid pipeline GeneXpert® Infinity System is a platform that combines flexibility with high throughput, automation, and compatibility, makes pathogen detection easier and more accessible by automating complex and time-consuming manual nucleic acid manipulations.

We look forward to win-win cooperation with Kingmed, empowering each other, jointly promoting the accurate diagnosis of infectious diseases in China, actively exploring the commercialization of clinically urgently needed diagnostic products, providing patients with better treatment plans as soon as possible, and contributing our strength to “Healthy China”!